Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Chen's Tang Shen Fang is a traditional Chinese medicine (TCM) herbal formula, likely based on or derived from the classic "Tangshen Formula" (TSF), which itself is used for diabetic nephropathy and related kidney disorders. The original TSF has demonstrated effects in reducing proteinuria, improving renal function, and modulating lipid metabolism in diabetic kidney disease. Mechanistically, TSF acts by promoting cholesterol efflux via upregulation of peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), Liver X receptors (LXR), and ATP-binding cassette subfamily A member 1 (ABCA1). Modified versions of such formulas typically involve adjustments to the herbal composition to target specific patient needs or syndromes according to TCM principles[3]. The precise composition of "modified Chen's Tang Shen Fang" is not specified in available sources but would be expected to include herbs aimed at nourishing Yin, tonifying Qi, regulating blood circulation, and supporting kidney function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Chen's Tang Shen Fang.